STHREE PLC (STEM) — Investment Research Note

Executive summary

SThree is a specialist STEM workforce consultancy placing contract and permanent talent (84% Contract / 16% Permanent) across Technology, Engineering and Life Sciences in 11 countries, with its three largest markets (Germany, USA, Netherlands) contributing ~73% of net fees. The operating trajectory has collapsed from a post-Covid peak (FY22 PBT £77m, FY24 £68m) to a cyclical trough (FY25 PBT £25m, FY26 guided ≥£12m), with sequential quarterly improvement — Q3 FY26 net fees down just 2% YoY vs -8% in Q1 — and new business activity now stabilising, led by the USA (+11% YoY in Q3). The single most important point for valuation is that shares have doubled from 158p (June 2026) to 293p against a Rule 28 Takeover Code consultation flagged on 22 September — the market is now pricing both cycle recovery and bid probability, leaving little margin of safety on fundamentals alone.

Fair value estimate

Methodology: Mid-cycle normalised earnings × sector multiple, cross-checked against trough/peak P/E. SThree is highly cyclical, so spot-earnings valuation is misleading.

• Normalised PBT: £45–65m (vs FY23 £78m peak, FY26 £12m trough; mid-cycle plausibly around £50m once DACH recovers and the German fiscal stimulus flows post-2027)
• Normalised net income: £34–49m (25% ETR)
• Normalised EPS: 28p–40p (120.7m shares)
• Multiple applied: 9–11x (specialist staffing peer range; Hays/PageGroup trading mid-single digits currently given cycle)

Fair value range: 250p – 350p per share → implied market cap £302m – £422m

• Mid-point: ~300p / ~£362m
• Latest market cap: £362m
• Absolute upside/downside: approximately 0% at mid-point (±20% at range extremes)

The shares are fair — the summer rally has largely captured both cycle recovery and takeover optionality. Without a bid, I'd anchor nearer the low end (250p).

Sector context

Classification is Industrial Goods and Services (ICB) — specifically specialist staffing/professional services. Listed peers: Hays plc (HAS), PageGroup (PAGE), Robert Walters (RWA). SThree screens as above-peer-quality on balance sheet (net cash £36m vs levered peers), above-peer specialisation (pure-play STEM, 84% Contract vs peers heavier Permanent), but similar cycle exposure. Operating profit conversion of 18% in FY24 was sector-leading before the current downturn.

Investment thesis

• High operating leverage into cycle recovery. FY24→FY26 shows PBT falling from £68m to £12m on net fees down ~15% — a dramatic illustration of fixed-cost gearing. Reversing this on a 10% revenue recovery could plausibly add £30-40m to PBT, with the completed Technology Improvement Programme providing additional efficiency uplift 2025-01-27 FY25 final results; 2026-07-21 half-year.
• Structural tailwinds in US and Life Sciences re-emerging. USA grew 11% in Q3 FY26, driven by demand for Engineering/Technology skills linked to power generation, data centre buildout and the AI value chain — a demonstrable AI-adjacent revenue line 2026-09-22 Q3 trading update. German fiscal stimulus (€500bn) is expected to disburse progressively from 2027 into Public Sector, Construction and STEM-intensive areas where SThree is positioned 2026-07-21 half-year.
• Fortress balance sheet with capital returns. £36m net cash, undrawn £50m RCF, £10.5m of £20m buyback completed, interim dividend maintained at 5.1p. Downside protection is strong relative to levered staffing peers 2026-09-22 Q3 trading update.

Key risks

• Rule 28 Takeover Code consultation implies bid speculation already priced. If no offer materialises, the shares could de-rate meaningfully given the current premium to trough fundamentals 2026-09-22 Q3 trading update.
• Structural AI-substitution risk in recruitment. Agentic AI could compress the economic value of candidate sourcing and screening — SThree is building its own tools but is simultaneously an indirect candidate for disruption; management acknowledges "the staffing sector" is being reshaped 2026-07-21 half-year.
• Germany persistence of weakness. DACH is 32% of Group net fees and declined 15% YoY in H1 FY26; the "progressive flow-through" of fiscal stimulus is a 2027+ story, meaning near-term earnings recovery is thin 2026-07-21 half-year.

Operating leverage

Operating leverage is very high and clearly observable in both directions. In H1 FY26, Group net fees fell 7% YoY (£159m → £148m) while operating profit collapsed 67% (£10.0m → £3.4m) — a decrementals ratio in excess of 60%. Running this in reverse: on management's own commentary at the September 2025 downgrade, approximately £20m of PBT was wiped out by the shortfall in new business activity due to "operational gearing" 2025-09-16 Q3 FY25 trading update. The cost base is largely fixed: ~£220m of staff costs (FY25) plus £13m of leases plus £17m depreciation/amortisation. Headcount is down 7% YoY period-end at Q3 FY26 after a 15% average reduction in H1 FY26, so the cost base is now leaner going into recovery. A 10-20% revenue beat vs plan would plausibly 2-3x operating profit from the current depressed base — this is the central operating-leverage case. The Contract model's 21.7% net fee margin is stable, so incremental fee pound drops at near-full gross margin against a largely fixed sales headcount — the "capacity-constrained services with pricing power" archetype in the investor profile.

Value-trap signals

• Three consecutive years of declining revenue and net fees (FY23 → FY25).
• FY25 PBT guidance was £25m, FY26 guidance has been c.£10m (now raised to £12m on one-offs) — a 75% peak-to-trough earnings fall.
• Dividend cover below 1.0x in FY25 (EPS 13.7p vs DPS 14.3p) — the Board explicitly "departed from policy" twice.
• Covenant waiver on guarantor cover (76% vs 80% threshold) in H1 FY26 — minor but worth monitoring.
• Interim CFO situation (Damian Fehrenberg) — permanent CFO Andrew Beach departed in 2026.

These suggest the stock is in a genuine cyclical trough, not a terminal-decline situation — but the window of persistent underperformance is becoming extended.

Earnings vs. expectations

Across the filings I can trace: FY23 full year was in line (£77.9m PBT vs guided levels); FY24 December 2024 trading update downgraded FY25 guidance to £25m and launched a buyback; FY25 September 2025 Q3 downgraded again to c.£10m FY26 PBT (vs then-consensus £30.5m — a severe miss); FY26 Q3 (September 2026) raised FY26 guidance to ≥£12m on one-off working capital benefits. Pattern: a sequence of material downgrades FY23 → FY25 followed by a modest beat in FY26 driven by one-offs that management explicitly says are not expected to recur. Track record is net negative on surprises through the cycle, though stabilisation is now visible.

Conviction

Conviction: 3 (moderate).

• Anchors: clean IFRS financials with strong cash flow disclosure; well-documented historic range of PBT (£12m–£78m) allows reasonable normalisation; large, visible operating leverage makes directional recovery call defensible.
• Caveats: Rule 28 Takeover Code consultation introduces M&A noise that fundamentals alone can't explain; cycle timing (particularly German recovery) is genuinely uncertain and structural AI-disruption risk to the recruitment business model is unresolved.